RePORT International Highlights

SUBMISSION DEADLINE: 27 January, 2026 Please refer to the website for the detials.

SUBMISSION PERIOD: 9 April - 16 May, 2026 The late-breaker abstract submission will be open from 9 April to 6 May 2026. Late-breaker submissions must introduce data of unquestioned significance that meet a high threshold of scientific merit. During abstract submission, authors will have to justify why their abstract should be considered as a late breaker. The same submission rules apply for late-breaker abstracts as for regular abstracts, but each presenting author may present only one late-breaker abstract at the conference. The percentage of abstracts selected as late breakers will depend on the number of submissions, but selection will be far more rigorous than for regular abstracts.

SUBMISSION DEADLINE: 27 January, 2026 If you are at least 18 years old on 26 July 2026 and working, volunteering or studying in the area of HIV, you are welcome to apply for a scholarship for AIDS 2026.

Deadline for Submission EXTENDED to January 9, 2026. The Union North America Region (NAR) is now accepting late-breaker abstract submissions for the Annual TB Conference 2026.

CONFERENCE DATE: 22-25 February, 2026; LOCATION: Denver, Colorado, USA The Conference on Retroviruses and Opportunistic Infections (CROI) was established in 1993 to provide a forum for basic scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases. The synergy of basic science and clinical investigation has been a major contributor to the success of the meeting. CROI has facilitated the presentation of important discoveries in the field, thereby accelerating progress in HIV and AIDS research. CROI highlights the latest research in HIV, hepatitis viruses, SARS-CoV-2 (including long COVID), mpox, and their related conditions.

The Conference on Retroviruses and Opportunistic Infections (CROI) was established in 1993 to provide a forum for basic scientists and clinical investigators to present, discuss, and critique their investigations into the epidemiology and biology of human retroviruses and associated diseases. The synergy of basic science and clinical investigation has been a major contributor to the success of the meeting. CROI has facilitated the presentation of important discoveries in the field, thereby accelerating progress in HIV and AIDS research. CROI highlights the latest research in HIV, hepatitis viruses, SARS-CoV-2 (including long COVID), mpox, and their related conditions. Abstracts are evaluated by the Scientific Program Committee and additional reviewers for the relevance of their topics, the rigor of their research, and the distinct contributions they make to the broad spectrum of study that CROI strives to provide each year. Attendance at the conference is open to researchers and clinical educators actively involved in the study and management of HIV, other retroviruses, and related medical conditions. Limited space is also available to members of the media whose work aligns with the scientific and educational aims of the conference. The 32nd CROI, held from February 22 to 25, 2026, is planned as an in-person conference in Denver, Colarado, USA.

E.W. "Al" Thrasher Awards focus on projects that are changing pediatric clinical care. Each award is a novel approach to problems plaguing pediatrics. The award is open to applications focusing on any disease or topic within the umbrella of pediatrics, both in and outside the United States. Ideal applications for the Thrasher Award address significant health problems, offering the potential for practical solutions to these problems. Typically, the primary outcome is a health outcome in children. Solutions should be innovative and have the potential for broad applicability with low barriers to implementation. Projects with a shorter distance to clinical applicability are given priority.​

DEADLINE: 13 January, 2026 The Consolidator Grant supports excellent Principal Investigators who are consolidating their own independent research team or programme. A Consolidator Grant Principal Investigatorshould have already shown evidence of research independence. Consolidator Grants may be awarded up to a maximum of EUR 2 000 000 for a period of 5 years. The maximum size of the grants is reduced pro rata temporis for proposals of shorter duration. The Principal Investigators shall have successfully defended their first PhD at least 7 and up to 12 years prior to 1 January 2026. Cut-off dates: Successful defence of PhD between 1 January 2014 and 31 December 2018 (inclusive). Applications can be made in any field of research. The ERC's grants operate on a 'bottom-up' basis without predetermined priorities.

Global Health EDCTP3 has launched its 2026 Work Programme, which includes six calls for proposals to support research and innovation projects addressing tuberculosis, lower respiratory tract infections, HIV, climate-change-driven infectious diseases and other pressing global health challenges. The calls for proposals will open for submission by mid-January 2026. To support interested applicants, an online Info Day will be held on 5 February 2026. During the event, participants will receive detailed information on the call topics, application process and evaluation criteria. Please refer to the webiste for the key dates and details.

APPLICATION DEADLINE: 15 February, 2026 The Weatherhead Scholars Program at the Weatherhead Center for International Affairs invites applications for its 2026–2027 Practitioner Fellowship, a one-year, residential opportunity for accomplished professionals from across the globe who are working on international, comparative, transnational, or global issues. Practitioner fellows join a multidisciplinary cohort—including postdoctoral researchers and visiting faculty—in residence at Harvard for the academic year. The program fosters a dynamic intellectual community through a weekly seminar, professional development workshops, and engagement with the broader Weatherhead Center and Harvard communities. Fellows are expected to be on campus from late August through mid-May and to participate actively in program activities.

SUBMISSION DEADLINE: 16 January, 2026. Please refer to the website for the details.

CONFERENCE DATE: 26-31 July 2026; LOCATION: Rio de Janeiro, Brazil and virtually Please refer to the website for the details.

CONFERENCE DATE: 12-15 May 2026; LOCATION: Dar es Salaam, Tanzania The annual INTEREST Conference is the premier scientific conference for HIV in Africa and brings together scientists involved in HIV treatment, pathogenesis, and prevention research from around the world. The conference will showcase cutting-edge knowledge in the diagnosis and treatment of HIV and the prevention of the HIV-1 infection. Additionally, it will continue to foster building a community of African physicians and scientists to facilitate the implementation of local solutions for the management of patients living with HIV-1 infection and for the prevention of HIV transmission. The programme will consist of invited lectures, oral abstract presentations, a debate, skill-building sessions, panel discussions, and sponsored symposia.

The JHU TRAC has partnered with RePORT International to offer Hopkins affiliates and their mentees the opportunity to enroll in JHU CANVAS asynchronous TB research courses. Select from the following courses: Epidemiology for TB Professional Development: Starting and Building Your Research Career Immunology for TB Introduction to Data Visualization Introduction to R Programming

Poster Abstract Deadline: 2 March, 2026 Early Registration Deadline: 22 January, 2026 The meeting will engage and feature the next generation of TB researchers to drive the field forward and foster cross-disciplinary insights and collaborations. TB mostly affects the Global South, but its research is poorly represented in scientific meetings. In contrast, early-career researchers from the Global South will be enabled to exchange ideas and discuss approaches and resources that are needed for future research with leading experts in the TB field. Please refer to the webiste for the key dates and details.

Application due date: Multiple dates, see announcement

Application due date: Multiple dates, see announcement

Application due date: Multiple dates, see announcement

APPLICATION DEADLINE: 1 February, 2026 The sub-Saharan Africa Health Research and Innovation Fellowship Program (SAHRI Fellowship Program) is an exceptional 3-year training program designed to empower 12 talented mid-career biomedical and clinical researchers from sub-Saharan Africa to become leaders in biomedical innovation and clinical research addressing the urgent challenges of infectious diseases across the continent. This fully-funded fellowship features three key phases: - advanced academic training in a research-oriented Master of Science in Tropical Medicine, - hands-on placements at premier African research institutions and BioNTech, and - a strategic return-home implementation phase The application opened on 1 October, 2025.

CONFERENCE DATE: 23-26 June, 2026; LOCATION: Phoenix, AZ, USA SER’s Annual Meeting brings together epidemiologists from around the world for a dynamic four-day experience of learning, connection, and celebration. Please refer to the website for the details.